Aim: Photobiomodulation involves the use of low-level light therapy or near-infrared light
therapy found to be useful in the treatment of a wide range of neurological diseases …

Photosensitive epilepsy is the most common subset of reflex epilepsy in humans. It is
characterized by an abnormal electroencephalogram trait known as photoparoxysmal …

Incompletely treated major depressive disorder (MDD) poses an enormous global health
burden. Conventional treatment for MDD consists of pharmacotherapy and psychotherapy …

Next to cancer, Alzheimer's disease (AD) and dementia is probably the most worrying health
problem facing the Western world today. A large number of clinical trials have failed to show …

The mechanisms underlying neuronal death following excessive activity such as occurs
during prolonged seizures are unclear, but mitochondrial dysfunction has been …

Mitochondrial function declines with age, and many pathological processes in
neurodegenerative diseases stem from this dysfunction when mitochondria fail to produce …

Three traumatic brain injuries (TBIs) occur every minute in the United States. TBI is a major
medical problem worldwide. 1 More than 5,000,000 Americans are living with TBI-related …

The application of photobiomodulation therapy (PBMT) for neuronal stimulation is studied in
different animal models and in humans, and has shown to improve cerebral metabolic …

Objective: A review of photobiomodulation (PBM) in Alzheimer's dementia is submitted. The
addition of PBM in neurodegenerative diseases is a dual modality that is at present gaining …

Parkinson's disease is the second most common neurodegenerative disease and is
increasing in incidence. The combination of motor and non-motor symptoms makes this a …